Human T- Lymphotropic Virus Type 1 in Blood Donors from Babol County Blood Transfusion Center: A Pilot Study From Northern Iran

Incidence of Human T-Lymphotropic Virus Type 1 (HTLV-1) among Blood Donors from Ilam, Iran

Designing a Human T-Lymphotropic Virus Type 1 (HTLV-I) Diagnostic Model Using the Complete Blood Count

Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.

OBJECTIVE To determine the seroprevalence of Human T-cell Lymphotropic Virus-1/2 (HTLV-1/2) in blood donors in Northern Pakistan. STUDY DESIGN Descriptive study. PLACE AND DURATION OF STUDY Armed Forces Institute of Transfusion, Rawalpindi, from July to August 2013. METHODOLOGY A total of 2100 blood donors were screened for anti-HTLV-1/2 antibodies during the study period, in a pool of si...

Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.

Previous studies have demonstrated the presence of human T-lymphotropic virus type I (HTLV-I) andlor HTLV type I1 (HTLV-11) in certain populations in Data on qualified blood donors are limited primarily to those in the southeast region of Brazil, while the country's 8,400,000 square miles include diverse geographic, climatic, and sociodemographic characteristics. To assist in the formulation of...

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.